Welcome to the ValueWiki BIONOMICS LIMITED (BNO.AX) article! Register for free or click the "edit" link to contribute!
BIONOMICS LIMITED (BNO.AX)
From ValueWiki
Business Description from asx.com.au: Developer of innovative treatments for cancer, mutiple sclerosis, anxiety and epilepsy.[1]
You can add information to this page! Just click any blue [ edit ] link to contribute.
|
|
[edit]
Company Analysis
You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.
The edit window has shortcut and help links if you need them.[2] Be bold!
[edit]
News Feed
[edit]
Leadership
- BIONOMICS LIMITED Executive Information
- BIONOMICS LIMITED Directors / Senior Management[1]
Dr Peter Jonson (Chairman, Non Exec. Director) Dr Deborah Rathjen (Managing Director, CEO) Mr Stephen Birrell (CFO) Dr George Jessup (Non Exec. Director) Mr Trevor Tappenden (Non Exec. Director)
[edit]
Risks
This section needs content! Click the blue edit link (to the right) to contribute.
[edit]
Research Links
- BIONOMICS LIMITED Profile
- BIONOMICS LIMITED Fundamentals
- BIONOMICS LIMITED Technical Analysis
- BIONOMICS LIMITED Contact Information[1]
- Website: http://www.bionomics.com.au/
- Address: 31 Dalgleish Street , THEBARTON , SA, AUSTRALIA, 5031
- Phone: 08 8354 6100
- Fax: 08 8354 6199
- Share Registry: COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 5 , 115 GRENFELL STREET , ADELAIDE , SA, AUSTRALIA, 5000
- Share Registry Phone: 1300 787 373 (BKR ONLY)
- BIONOMICS LIMITED Message Boards
[edit]
Notes
- ↑ 1.0 1.1 1.2 http://www.asx.com.au/asx/research/CompanyInfoSearchResults.jsp?searchBy=asxCode&allinfo=on&asxCode=BNO ASX.com.au
- ↑ This is a sample reference.
